In GnRH antagonist protocols, a GnRH agonist trigger is often administered when at least three follicles reach 17 mm to reduce the risk of Ovarian Hyperstimulation Syndrome (OHSS) while maintaining a good oocyte maturation rate [24,27]. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.